HLA-A*1101 & B2M & KRASG12A (VVVGAAGVGK)

HLA-A*1101 & B2M & KRASG12A (VVVGAAGVGK) Product List

  • Product Category

    Protein (1)

  • Product Status

    Launched (1)

  • Species

    Human (1)

  • Tag

    His Tag & Avi Tag (1)

  • Conjugate

    Biotin-labeled (1)

Cat. No.SpeciesHostProduct DescriptionStructurePurityFeature
HLA-H82E9
Human
HEK293
Biotinylated Human HLA-A*11:01&B2M&KRASG12A (VVVGAAGVGK) Complex Protein (Monomer, MALS verified)
Total: 1
  • 1

HLA-A*1101 & B2M & KRASG12A (VVVGAAGVGK) Background

The Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) oncogene plays a critical role in the initiation and maintenance of pancreatic tumors and its signaling network represents a major target for therapeutic intervention. The Biotinylated Human HLA-A*1101 KRASG12A (VVVGAAGVGK) complex protein is a complex of HLA-A*1101 of the MHC Class I, B2M, and VVVGAAGVGK peptide of the KRASG12A.

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
CB-2202CB-2202Phase 2 ClinicalCennerv PharmaDepressive Disorder, Major
Details

Marketed Drug Information

English NameResearch CodeHighest Development StageCompanyEarliest Brand NameEarliest Approval CountryEarliest IndicationEarliest Approval CompanyEarliest Approval DateIndicationClinical Trial
ToloxatoneMD-69276ApprovedUmoril, Humoryl, PerenumFranceDepressionnull1984-01-01Depression
Details
  • Product List
  • Marketed Drug Information
  • Clinical Drug Information
Contact Us

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8